Is the PARADIGM-HF cohort representative of the real-world heart failure patient population?
{{output}}
Introduction: A new drug with prognostic impact on heart failure, sacubitril/valsartan, has been introduced in current guidelines. However, randomized trial results can be compromised by lack of representativeness. We aimed to as... ...
